Oncognse des tumeurs respiratoires et urognitales - Service d ...
Oncognse des tumeurs respiratoires et urognitales - Service d ...
Oncognse des tumeurs respiratoires et urognitales - Service d ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
GETU<br />
92. Salomon, L., Anastasiadis, A. G., Levrel, O., Katz, R., Saint, F., de la Taille, A., Cicco, A., Vordos, D.,<br />
Hoznek, A., Chopin, D., and Abbou, C. C. Location of positive surgical margins after r<strong>et</strong>ropubic, perineal,<br />
and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology, 61: 386-390, 2003.<br />
93. Pfister, C., Chautard, D., Devonec, M., Perrin, P., Chopin, D., Rischmann, P., Bouchot, O., Beurton, D.,<br />
Coulange, C., and Rambeaud, J. J. Immunocyt test improves the diagnostic accuracy of urinary cytology:<br />
results of a French multicenter study. J Urol, 169: 921-924, 2003.<br />
94. Vivo, C., Lecomte, C., Levy, F., Leroy, K., Kirova, Y., Renier, A., Kheuang, L., Piedbois, P., Chopin, D.,<br />
and Jaurand, M. C. Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to<br />
gamma radiation. Br J Cancer, 88: 388-395, 2003.<br />
95. van Rhijn, B. W., Lurkin, I., Chopin, D. K., Kirkels, W. J., Thiery, J. P., van der Kwast, T. H., Radvanyi, F.,<br />
and Zwarthoff, E. C. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive<br />
d<strong>et</strong>ection of urothelial cell carcinoma in voided urine. Clin Cancer Res, 9: 257-263, 2003.<br />
96. Salomon, L., Levrel, O., Anastasiadis, A. G., Irani, J., De La Taille, A., Saint, F., Vordos, D., Cicco, A.,<br />
Hoznek, A., Chopin, D., and Abbou, C. C. Prognostic significance of tumor volume after radical<br />
prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol, 43: 39-44, 2003.<br />
97. Bakkar A, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, Kouyoumdjian JC, Abbou CC, Pairon<br />
JC, Jaurand MC, Thiery JP, Chopin DK, Gil Diez De Medina S. FGFR3 and TP53 gene mutations define<br />
two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Research, 63: 8108-8112, 2003<br />
Année 2004<br />
98. Céraline J., Cruchant M.D., Erdmann E. , Erbs Ph., Kurtz J.E., Duclos B., Jacqmin D., Chopin D., and<br />
Bergerat J.P. Constitutive activation of the androgen receptor by a point mutation in the hinge region : a new<br />
mechanism for androgen-independent growth in prostate cancer. Int J Cancer, 108:152-157, 2004<br />
99. Popov Z, Gil-Diez De Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Le Frere-Belda MA, Abbou CC,<br />
Chopin DK. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer. Urol Oncol,<br />
2004, 22:00-00<br />
100. Daher A., De Boer W.I., Le Frère Belda M.A., Kheuang L., Abbou C.C., Radvanyi F., M.C. Jaurand, Thiery<br />
J.P., Gil Diez de Medina S., Chopin D.K. Growth, differentiation and Senescence of Normal Human<br />
Urothelium in organ like culture. European Urology, (45) 799-805, 2004<br />
101. Huguenin S, Vacherot F, Kheuang L, Fleury-Feith J, Jaurand MC, Bolla M, Riffaud JP, Chopin DK.<br />
Antiproliferative effect of nitrosulindac (NCS 1102), a new nitric oxide-donating non steroidal antiinflammatory<br />
drug (NO-NSAID), on human bladder carcinoma cell lines. Mol Cancer Ther. 3 (3):1-9, 2004<br />
102. Huguenin S, Fleury-Feith J, Kheuang L, Jaurand MC, Bolla M, Riffaud JP, Chopin D, Vacherot F.<br />
Nitrosulindac (NCS 1102), a new nitric oxide-donating non steroidal antiinflammatory drug (NO-SAIDS),<br />
inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. The Prostate, (sous<br />
presse)<br />
103. Makhoul B, De La Taille A, Salomon P, Sebe P, Aud<strong>et</strong> JF, Ruiz L, Hoznek A, Antiphon P, Cicco A, Vordos<br />
D, Yiou R, Chopin D, Abbou C. C. Laparoscopic radical nephrectomy for T1 renal cancer : the gold<br />
standard A comparison of laparoscopic vs open nephrectomy. Br J Urol, (sous presse)<br />
104. Saint F., Le Frère Belda M.A., Quintela R., Hoznek A., Patard J.J., Bellot J., Popov Z., Zafrani E.S., Abbou<br />
C.C., D. Chopin, S. Gil Diez de Medina. Pr<strong>et</strong>reatment in p53 overexpression as a prognostic marker in<br />
superficial bladder cancer treated with Bacillus Calm<strong>et</strong>te-Guérin (BCG). Eur Urol, 2004 in press<br />
26